Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
China flag China · Delayed Price · Currency is CNY
6.86
+0.09 (1.33%)
Feb 4, 2026, 3:00 PM CST

SHA:600351 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
2,2392,6522,8802,6812,6812,556
Other Revenue
34.5234.5229.4637.4583.246.85
2,2732,6862,9102,7182,7642,602
Revenue Growth (YoY)
-19.73%-7.69%7.05%-1.66%6.21%-14.45%
Cost of Revenue
1,1181,3231,2461,2161,0951,073
Gross Profit
1,1561,3631,6641,5021,6691,529
Selling, General & Admin
706.08913.511,2281,1591,2961,235
Research & Development
121.9139.52118.29130.62157.13144.46
Other Operating Expenses
38.4631.3931.3433.9833.3834.31
Operating Expenses
858.741,0861,3731,3241,4731,412
Operating Income
296.9276.84291.5178.07196.65117.42
Interest Expense
-1.78-5.35-12.3-18.77-22.61-32.61
Interest & Investment Income
6.496.459.498.1822.044
Currency Exchange Gain (Loss)
0.050.05-0.030.27-0.13-0.17
Other Non Operating Income (Expenses)
11.425.96-9.75-8.01-3.53-4.24
EBT Excluding Unusual Items
313.07283.95278.91159.74192.4284.4
Impairment of Goodwill
----48.3--
Gain (Loss) on Sale of Investments
-2.05-3.04-5.35-4.171.343.34
Gain (Loss) on Sale of Assets
0.140.351.120.120.152.63
Asset Writedown
-87.11-27.53-84.97-9.75-22.97-3.44
Other Unusual Items
37.4238.3729.2628.0230.6640.49
Pretax Income
261.46292.11218.98125.65201.59127.42
Income Tax Expense
67.5268.1939.0721.0417.8318.43
Earnings From Continuing Operations
193.94223.92179.91104.6183.76108.99
Minority Interest in Earnings
28.9118.7719.670.053.33-1.62
Net Income
222.85242.69199.59104.66187.09107.37
Net Income to Common
222.85242.69199.59104.66187.09107.37
Net Income Growth
0.97%21.60%90.71%-44.06%74.25%672.05%
Shares Outstanding (Basic)
706723763770770770
Shares Outstanding (Diluted)
706723763770770770
Shares Change (YoY)
-3.67%-5.25%-0.89%0.02%-0.04%-0.86%
EPS (Basic)
0.320.340.260.140.240.14
EPS (Diluted)
0.320.340.260.140.240.14
EPS Growth
4.82%28.34%92.42%-44.07%74.32%678.77%
Free Cash Flow
500.83437.03397.7398.23342.45318.09
Free Cash Flow Per Share
0.710.600.520.520.450.41
Dividend Per Share
0.5000.3000.1500.0500.0800.050
Dividend Growth
233.33%100.00%200.00%-37.50%60.00%150.00%
Gross Margin
50.84%50.73%57.19%55.27%60.39%58.77%
Operating Margin
13.06%10.31%10.02%6.55%7.12%4.51%
Profit Margin
9.80%9.04%6.86%3.85%6.77%4.13%
Free Cash Flow Margin
22.03%16.27%13.67%14.65%12.39%12.22%
EBITDA
418.15412.82447.11338.04363.93287.3
EBITDA Margin
18.39%15.37%15.37%12.44%13.17%11.04%
D&A For EBITDA
121.25135.98155.61159.97167.27169.88
EBIT
296.9276.84291.5178.07196.65117.42
EBIT Margin
13.06%10.31%10.02%6.55%7.12%4.51%
Effective Tax Rate
25.82%23.34%17.84%16.75%8.85%14.46%
Revenue as Reported
2,2732,6862,9102,7182,7642,602
Advertising Expenses
-131.24119.31105.5100.4992.83
Source: S&P Global Market Intelligence. Standard template. Financial Sources.